- Home
- CDIO vs VEEE Comparison
CDIO vs VEEE Comparison
Compare CDIO & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- VEEE
- Stock Information
- Founded
- CDIO 2017
- VEEE 1994
- Country
- CDIO United States
- VEEE United States
- Employees
- CDIO N/A
- VEEE N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- VEEE Marine Transportation
- Sector
- CDIO Health Care
- VEEE Industrials
- Exchange
- CDIO Nasdaq
- VEEE Nasdaq
- Market Cap
- CDIO 6.4M
- VEEE 5.8M
- IPO Year
- CDIO N/A
- VEEE 2021
- Fundamental
- Price
- CDIO $3.63
- VEEE $2.05
- Analyst Decision
- CDIO Buy
- VEEE
- Analyst Count
- CDIO 1
- VEEE 0
- Target Price
- CDIO $60.00
- VEEE N/A
- AVG Volume (30 Days)
- CDIO 41.9K
- VEEE 129.5K
- Earning Date
- CDIO 08-14-2025
- VEEE 08-07-2025
- Dividend Yield
- CDIO N/A
- VEEE N/A
- EPS Growth
- CDIO N/A
- VEEE N/A
- EPS
- CDIO N/A
- VEEE N/A
- Revenue
- CDIO $19,507.00
- VEEE $13,153,262.00
- Revenue This Year
- CDIO $1,434.82
- VEEE N/A
- Revenue Next Year
- CDIO $4,661.91
- VEEE N/A
- P/E Ratio
- CDIO N/A
- VEEE N/A
- Revenue Growth
- CDIO N/A
- VEEE N/A
- 52 Week Low
- CDIO $3.22
- VEEE $1.88
- 52 Week High
- CDIO $53.10
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- CDIO 41.96
- VEEE 40.59
- Support Level
- CDIO $3.58
- VEEE $2.00
- Resistance Level
- CDIO $4.05
- VEEE $2.13
- Average True Range (ATR)
- CDIO 0.33
- VEEE 0.21
- MACD
- CDIO -0.01
- VEEE -0.03
- Stochastic Oscillator
- CDIO 24.74
- VEEE 20.24
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.